NCT00785811
Terminated
Phase 4
Randomized, Double Blind, Placebo Controlled Study of Parallel Groups to Evaluate the Effect of Chronic Supplementation of L-arginine in the Muscular Performance.
ConditionsMuscular Fatigue
Overview
- Phase
- Phase 4
- Status
- Terminated
- Sponsor
- Sanofi
- Enrollment
- 36
- Locations
- 1
- Primary Endpoint
- Fatigue Resistance Factor (FRF)
Overview
Brief Summary
The primary purpose of this study is to evaluate the effect of oral administration of L-arginine in the muscular fatigue of the quadriceps, expressed in terms of the Fatigue Resistance Factor (FRF). The secondary purpose of this study is to evaluate the effect of oral administration of L-arginine in the muscular force the quadriceps.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Supportive Care
- Masking
- Double (Participant, Investigator)
Eligibility Criteria
- Ages
- 20 Years to 55 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Arms & Interventions
1
Experimental
L-arginine aspartate (Targifor)
Intervention: L-arginine aspartate (Targifor) (Drug)
2
Placebo Comparator
Placebo
Intervention: Placebo L-arginine aspartate (Targifor) (Drug)
Outcomes
Primary Outcomes
Fatigue Resistance Factor (FRF)
Time Frame: Throughout the study
Secondary Outcomes
- Maximum force in Newton (N) and fast or explosive force(at time 90% of the maximum isometric force)
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 1
Efficacy Study of Oral Arginine to Improve Immune Function in Glioblastoma MultiformeGlioblastoma MultiformeNCT02017249Inova Health Care Services1
Completed
Phase 4
L-Arginine and Erectile DysfunctionErectile DysfunctionNCT00777075Hannover Medical School57
Completed
Not Applicable
The Effect of L-arginine in the treatment of Sickle Cell Anemiasickle cell anemiaD57.1C15.378.071.141.150.150RBR-2t56nzniversidade Federal do Ceará
Completed
Phase 2
Arginine Therapy for Sickle Cell Disease PainSickle Cell DiseaseVaso-occlusive Pain EpisodeNCT02536170Emory University108
Not yet recruiting
Phase 3
The effect of L-arginine in non-alcoholic fatty liverIRCT20230409057859N1Shahid Beheshti University of Medical Sciences60